Strategic Overview

Hugo Biotech develops TB-EASY and TB Pro, decentralized molecular tests and targeted NGS solutions for TB diagnosis and drug resistance testing.

Innovation Portfolio

TB-EASY
Category: DIAGNOSIS Stage: Late Stage

Innovative diagnostic solution.

Decent. Mol. Swab/Sputum
TB Pro
Category: DRUG RESIST. Stage: Late Stage

Innovative diagnostic solution.

tNGS Various

Key Milestones

TB-EASY decentralized molecular test
89.6% sensitivity for tongue samples
TB Pro targeted NGS for comprehensive resistance profile
Multiple disease target capability